Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells.
Recent evidence suggests the possibility that macrophages can influence lipoprotein metabolism. Therefore we investigated the ability of cultured macrophages to alter low density lipoprotein (LDL) uptake in a human liver cell line (HepG2). Conditioned media from phlogogenic-induced mouse peritoneal macrophages or from a human macrophage cell line stimulated with endotoxin increased HepG2 LDL uptake by as much as 60-70%. The increase was due, in part, to a significant macrophage-induced 40% increase in the number of LDL receptors per cell. Although macrophage conditioned media inhibited HepG2 cholesterol synthesis, the LDL receptor up-regulation did not appear to be due to the effects on cholesterol synthesis. The LDL receptor stimulatory activity was sensitive to proteolysis and heat. Its molecular mass was approximately 20 kDa based on gel filtration. Several macrophage secretory proteins were tested in HepG2 cultures for LDL uptake stimulation. Of these, oncostatin M (approximately 18 kDa by gel filtration) gave the strongest response. The rank order for LDL uptake stimulation was oncostatin M much greater than interleukin 6 = interleukin 1 = transforming growth factor-beta 1. A neutralizing antibody directed against oncostatin M inhibited the ability of conditioned media to up-regulate LDL receptors by 85%. Thus, our results indicate that macrophages can secrete several proteins that up-regulate LDL receptors in HepG2 cells and that most of the up-regulatory activity in macrophage conditioned media appears to be due to oncostatin M.
Grove
R I
RI
Oncogen, Bristol-Myers Squibb PRI, Seattle, WA 98121.
Mazzucco
C
C
Allegretto
N
N
Kiener
P A
PA
Spitalny
G
G
Radka
S F
SF
Shoyab
M
M
Antonaccio
M
M
Warr
G A
GA
D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D002784:Cholesterol / Q000096:biosynthesis; D016207:Cytokines / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007378:Interleukins / Q000494:pharmacology*; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D053683:Oncostatin M; D010455:Peptides / Q000494:pharmacology*; D011973:Receptors, LDL / Q000187:drug effects* / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
D016207:Cytokines; D007378:Interleukins; C508351:OSM protein, human; C508352:Osm protein, mouse; D010455:Peptides; D011973:Receptors, LDL; D016212:Transforming Growth Factor beta; D053683:Oncostatin M; D002784:Cholesterol